#United States #Radnor #Shareholder Value #Avantor #Emmanuel Ligner

Avantor's Commitment to Shareholder Value

Avantor, Inc., a prominent player in the life sciences and advanced technology sectors, has reaffirmed its dedication to creating sustained shareholder value in a recent statement following a communication from Engine Capital. The company’s Board of Directors is fully engaged in shaping and executing its strategic direction, ensuring that their actions consistently support the best interests of both the company and its shareholders.

In its public disclosure, Avantor highlighted its exceptional position in the marketplace, fueled by a comprehensive portfolio that caters to the dynamic landscape of research and production. The company benefits from a robust global distribution network and strong, longstanding relationships with its clients across the life sciences industry. These elements align to provide Avantor with the tools necessary to enhance growth and profitability in its Laboratory Solutions and Bioscience Production segments.

Over the last year and a half, the Board has undertaken noteworthy initiatives that underscore its commitment to improving company performance. This includes the appointment of a new Chief Executive Officer and a new head for Lab Solutions. Significant milestones such as the launch of a $400 million cost transformation initiative, bolstered transparency through business re-segmentation, and ongoing portfolio adjustments have also been notable aspects of Avantor’s strategy. Additionally, the company has actively worked on a focused capital allocation strategy, which has successfully reduced its leverage by nearly $1.5 billion during this period.

The upcoming transition to Emmanuel Ligner as the new Chief Executive Officer on August 18, 2025, marks another pivotal moment for Avantor. Ligner brings a proven track record in fostering value creation within the life sciences sector and is anticipated to spearhead the acceleration of the company's strategic initiatives. The Board expresses confidence in Ligner’s ability to lead the corporation towards achieving its value creation goals.

Avantor's strategy reflects a dual focus on immediate performance enhancement and long-term value generation. The consistent dialogue between the Board and shareholders, including with entities like Engine Capital, is essential for aligning goals and maintaining transparency in decision-making processes.

Goldman Sachs & Co. LLC along with Gordon Dyal & Co. acts as Avantor's financial advisors, while Paul, Weiss, Rifkind, Wharton & Garrison LLP offers legal guidance. Joele Frank, Wilkinson Brimmer Katcher is also engaged as a strategic communications adviser.

About Avantor

Avantor® is recognized as a leading company in life science tools and a global provider of critical products and services tailored for upholding high standards required in scientific endeavors. Collaborating closely with customers throughout the scientific journey, Avantor aims to facilitate breakthroughs in medicine, healthcare, and technology. Its extensive portfolio finds application in virtually every phase of pivotal research, development, and production efforts across over 300,000 customer locations across 180 nations.

Embarking on plans to continually refine its operations, Avantor stands poised for future success. Through strategic innovations and a steadfast commitment to shareholder value, the company is dedicated to enhancing its role as a crucial partner in the life sciences domain. For more insights, visit avantorsciences.com and connect with Avantor on LinkedIn, X (Twitter), and Facebook.

Forward-Looking Statements

This communication may contain forward-looking statements regarding future events and financial performance, which are subject to risks and uncertainties. Historical information should not be relied upon for predictions about future outcomes. Avantor does not undertake any obligation to update or revise these statements unless required by federal securities laws.